Lumira Ventures — 2016 Investments
1 investments dated 2016 · listed companies and verified rows first · show all
Endotronix develops the Cordella PA Sensor and Heart Failure System, an FDA-approved implantable pulmonary artery pressure sensor and remote monitoring platform for managing patients with NYHA class III heart failure.
Digital HealthHealthtechMedical DevicesWoodridge, US
Harry Rowland(Executive Officer, Director)Anthony I Nunez(Executive Officer, Director)Anthony A. Nunez(Executive Officer, Director)Anthony Nunez(Founder)in
BoardJonathan Jonas(Director)Raymond S. Barrett, Jr.(Director)
Board seatGerry Brunk· per SEC Form D
Co-investorsBioventures InvestorsJumpstart VenturesOSF VenturesSeroba Life SciencesSV Health Investors
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.